LA
DXCM icon

Legacy Advisors’s DexCom DXCM Stock Holding History

Legacy Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$746K Buy
10,929
+895
+9% +$73K 0.08% 203
2024
Q4 		$780K Buy
10,034
+1,315
+15% +$97.4K 0.08% 198
2024
Q3 		$585K Sell
8,719
-817
-9% -$67.1K 0.06% 225
2024
Q2 		$1.08M Buy
9,536
+201
+2% +$25.4K 0.13% 123
2024
Q1 		$1.29M Buy
9,335
+743
+9% +$93.4K 0.16% 110
2023
Q4 		$1.07M Buy
8,592
+2,008
+30% +$205K 0.14% 125
2023
Q3 		$614K Buy
6,584
+852
+15% +$96K 0.1% 167
2023
Q2 		$737K Buy
5,732
+332
+6% +$40.2K 0.11% 141
2023
Q1 		$627K Buy
5,400
+879
+19% +$98.4K 0.12% 130
2022
Q4 		$512K Buy
4,521
+1,418
+46% +$156K 0.09% 143
2022
Q3 		$250K Buy
+3,103
New +$263K 0.06% 187

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Legacy Advisors's DXCM Position: Q1 2025 in Review

Legacy Advisors increased its DexCom (DXCM) stake by 8.9% in Q1 2025, buying an estimated $73K and bringing the position to 10,929 shares worth $746K. The position accounts for 0.08% of the portfolio, ranked #203.

Legacy Advisors first reported a position in DXCM in Q3 2022 and has held it in 11 quarters since. The position peaked at $1.29M in Q1 2024. 934 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

  • Legacy Advisors held 10,929 shares of DexCom worth $746K as of Q1 2025.
  • Legacy Advisors bought 895 DexCom shares in Q1 2025, an estimated $73K.
  • DexCom made up 0.08% of Legacy Advisors's portfolio in Q1 2025, its #203 holding.
  • Legacy Advisors first reported a position in DexCom in Q3 2022 and has held it in 11 quarters since.
  • Legacy Advisors's DexCom position peaked at $1.29M in Q1 2024.
  • 934 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on Legacy Advisors's 13F filing for Q1 2025, filed 23 Apr 2025.